ACCOUNT

Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

PGe
NEWSLETTERS
PG STORE
ARCHIVES

CLASSIFIEDS

OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS

CONTACT US
ADVERTISING
CAREER OPPORTUNITIES

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.065 -0.005 (-0.47%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

36 37 Next >

Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection ↗

March 04, 2022

Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; U.S. Economy Adds 678,000 Jobs ↗

March 04, 2022

U.S. stocks opened on a downbeat note this morning following the release of weekly jobless claims data. Following the market opening Friday, the Dow traded down 1.29% to 33,360.18...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 04, 2022

Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo...

Via Benzinga

FDA Denies Pediatric EUA To Ocugen For Bharat Biotech's COVID-19 Vaccine Covaxin ↗

March 04, 2022

The FDA has declined to issue an Emergency Use Authorization (EUA) for Covaxin for active immunization to prevent COVID-19 in individuals 2 to 18 years of age. Ocugen...

Via Benzinga

Why Ocugen Shares Are Falling ↗

March 04, 2022

Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 22.8%...

Via Benzinga

Recap: Ocugen Q4 Earnings ↗

February 25, 2022

Ocugen (NASDAQ:OCGN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Also check...

Via Benzinga

Why Ocugen Shares Are Falling ↗

February 23, 2022

Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 19.6%...

Via Benzinga

The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan ↗

March 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck's Keytruda Evaluated In Combination With Microbiome Therapeutic In...

Via Benzinga

Looking Into Ocugen Inc's Recent Short Interest ↗

March 02, 2022

Ocugen Inc's (NASDAQ:OCGN) short percent of float has risen 8.35% since its last report. The company recently reported that it has 54.94 million shares sold short, which is 30.23...

Via Benzinga

Earnings Scheduled For February 25, 2022 ↗

February 25, 2022

Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...

Via Benzinga

63 Biggest Movers From Yesterday ↗

February 24, 2022

Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a...

Via Benzinga

Is OCGN Stock a Buy After 20% Plunge? One Analyst Thinks It Can Go to $15. ↗

February 23, 2022

Ocugen is down more than 20% after announcing a common stock offering. Could this possibly present a buying opportunity for OCGN stock?

Via InvestorPlace

February 23, 2022

These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold.

Via InvestorPlace

40 Stocks Moving In Wednesday's Mid-Day Session ↗

February 23, 2022

Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share...

Via Benzinga

Vertiv News: Why Is VRT Stock Plunging Today? ↗

February 23, 2022

Vertiv (VRT) stock isn't doing so hot on Wednesday following the release of the manufacturing company's earnings report for Q4 2021.

Via InvestorPlace

OCGN Stock Alert: The $50 Million Reason Ocugen Is Tanking Today ↗

February 23, 2022

After rising sharply in recent days, Ocugen shares are again falling on news that the company is issuing $50 million of common stock.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 23, 2022

Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

23 Stocks Moving in Wednesday's Pre-Market Session ↗

February 23, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the...

Via Benzinga

73 Biggest Movers From Yesterday ↗

February 23, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 22, 2022

Gainers Revelation Biosciences (NASDAQ:REVB

Via Benzinga

Ocugen Is Too Uncertain as Time Runs Out for Covaxin’s Approval ↗

February 22, 2022

Ocugen's path to entry in the North American market is highly uncertain, making OCGN stock a remarkably risky bet at this point.

Via InvestorPlace

Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher ↗

February 22, 2022

U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led...

Via Benzinga

Production Updates Could Give Novavax Stock a Big Boost ↗

February 22, 2022

Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 22, 2022

Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,...

Via Benzinga

Mid-Day Market Update: Stocks Extend Losses; Dow Tumbles Over 400 Points ↗

February 22, 2022

U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would...

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

February 22, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...

Via Benzinga

Dow Drops Triple Digits as Investors Eye Sanctions ↗

February 22, 2022

The Dow Jones Industrial Average is down 292 points midday. The S&P 500 Index and Nasdaq Composite are sharply lower as well, as the major indexes begin their holiday-shortened week after their...

Via Talk Markets

Dear AMC Stock Fans, Mark Your Calendars for March 1 ↗

February 22, 2022

Investors in AMC Entertainment (AMC) stock are going to want to keep an eye on the movie theater company when March 1 rolls around.

Via InvestorPlace

Chinese Stocks Alert: Why Are BABA, TCEHY, JD, PDD Stocks Down Today? ↗

February 22, 2022

Chinese tech stocks are taking a beating on Tuesday as investors worry about additional restrictions from the country's government.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.